Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haugen, S.
Right arrow Articles by Hiatt, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugen, S.
Right arrow Articles by Hiatt, W. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Risk assessment in the patient with established peripheral arterial disease

Scott Haugen

Divisions of Cardiology and General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA

Ivan P. Casserly

Divisions of Cardiology and General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA, Denver Veterans Administration Medical Center, Denver, CO, USA

Judith G. Regensteiner

Divisions of Cardiology and General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA

William R. Hiatt

Divisions of Cardiology and General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA, Colorado Prevention Center, Denver, CO, USA, Will.Hiatt{at}uchsc.edu

Office-based cardiovascular risk prediction continues to challenge practitioners in primary and secondary risk stratification settings. In patients with established peripheral arterial disease (PAD), the risk of cardiovascular events (i.e. death or morbidity due to coronary heart disease and/or cerebrovascular disease) is high, yet traditional risk factors and the ankle—brachial index (ABI) do not provide a complete secondary risk prediction. In this population, office-based cardiovascular risk stratification may be improved by surrogate markers of the systemic atherosclerotic burden, as well as markers of systemic inflammation. This review will evaluate the utility of the ABI, clinical stage of disease, and the emerging role of C-reactive protein (CRP) and other inflammatory markers in secondary risk prediction in PAD. Defining which patients are in the highest category of risk may direct health care providers to emphasize secondary preventive measures, and facilitate patient adherence to recommended medical therapies and smoking cessation.

Key Words: atherosclerosis • cardiovascular diseases • C-reactive protein • inflammation • peripheral vascular diseases • risk assessment

References

  • Kistorp C. Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics? Circulation 2006; 114: 184—86.[Free Full Text]
  • Resnick HE, Lindsay RS, McDermott MM et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733—39.[Abstract/Free Full Text]
  • Diehm C., Lange S., Darius H. et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 27: 1743—49.[Abstract/Free Full Text]
  • Leng GC, Fowkes FG, Lee AJ, Dunbar J., Housley E., Ruckley CV Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996; 313: 1440—44.[Abstract/Free Full Text]
  • Grundy SM, Pasternak R., Greenland P., Smith S. Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100: 1481—92.[Free Full Text]
  • Faxon DP, Creager MA, Smith SC Jr et al. Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2004; 109: 2595—604.
  • Aboyans V., Criqui MH Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 2006; 59: 547—58.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Newman AB, Siscovick DS, Manolio TA et al. Ankle—arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837—45.[Abstract/Free Full Text]
  • Zheng ZJ, Sharrett AR, Chambless LE et al. Associations of ankle—brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 115—25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Abbott RD, Petrovitch H., Rodriguez BL et al. Ankle/brachial blood pressure in men > 70 years of age and the risk of coronary heart disease. Am J Cardiol 2000; 86: 280—84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Menke A., Muntner P., Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Agnelli G., Cimminiello C., Meneghetti G., Urbinati S. Low ankle—brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006; 4: 2599—606.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Aboyans V., Lacroix P., Postil A. et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2005; 46: 815—20.[Abstract/Free Full Text]
  • Beckman JA, Jaff MR, Creager MA The United States Preventive Services Task Force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation 2006; 114: 861—66.[Abstract/Free Full Text]
  • Hooi JD, Stoffers HE, Kester AD, van Ree JW, Knottnerus JA Peripheral arterial occlusive disease: prognostic value of signs, symptoms, and the ankle—brachial pressure index. Med Decis Making 2002; 22: 99—107.[Abstract/Free Full Text]
  • Beckman JA, Preis O., Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol 2005; 96: 1374—78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mehler PS, Coll JR, Estacio R., Esler A., Schrier RW, Hiatt WR Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003; 107: 753—56.[Abstract/Free Full Text]
  • Norgren L., Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1S): S5—S67.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brevetti G., Martone VD, Perna S. et al. Intermittent claudication and risk of cardiovascular events. Angiology 1998; 49: 843—48.[Web of Science][Medline] [Order article via Infotrieve]
  • Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993; 270: 465—69.[Abstract/Free Full Text]
  • McDermott MM, Feinglass J., Slavensky R., Pearce WH The ankle—brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 1994; 9: 445—49.[Web of Science][Medline] [Order article via Infotrieve]
  • Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 1989; 9: 691—97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bowers BL, Valentine RJ, Myers SI, Chervu A., Clagett GP The natural history of patients with claudication with toe pressures of 40mm Hg or less. J Vasc Surg 1993; 18: 506—11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • O'Hare AM, Katz R., Shlipak MG, Cushman M., Newman AB Mortality and cardiovascular risk across the ankle—arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006; 113: 388—93.[Abstract/Free Full Text]
  • Rutherford RB, Baker JD, Ernst C. et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517—38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Criqui MH, Langer RD, Fronek A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381—86.[Abstract]
  • Schmieder FA, Comerota AJ Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol 2001; 87(12A): 3D—13D.[Web of Science][Medline] [Order article via Infotrieve]
  • Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172—81.[Abstract/Free Full Text]
  • Hooi JD, Stoffers HE, Kester AD, van Ree JW, Knottnerus JA Peripheral arterial occlusive disease: prognostic value of signs, symptoms, and the ankle—brachial pressure index. Med Decis Making 2002; 22: 99—107.[Abstract/Free Full Text]
  • Jelnes R., Gaardsting O., Hougaard JK, Baekgaard N., Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J (Clin Res Ed) 1986; 293: 1137—40.[Medline] [Order article via Infotrieve]
  • Dormandy J., Mahir M., Ascady G. et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989; 30: 50—57.[Medline] [Order article via Infotrieve]
  • Marston WA, Davies SW, Armstrong B. et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006; 44: 108—14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pasqualini L., Schillaci G., Vaudo G., Innocente S., Ciuffetti G., Mannarino E. Predictors of overall and cardiovascular mortality in peripheral arterial disease. Am J Cardiol 2001; 88: 1057—60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brass EP, Anthony R., Dormandy J. et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 2006; 43: 752—59.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Meijer WT, Hoes AW, Rutgers D., Bots ML, Hofman A., Grobbee DE Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185—92.[Abstract/Free Full Text]
  • Weitz JI, Byrne J., Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94: 3026—49.[Free Full Text]
  • Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol 1994; 23: 1091—95.[Abstract]
  • Cimminiello C. PAD. Epidemiology and pathophysiology. Thromb Res 2002; 106: V295—V301.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brevetti G., Schiano V., Verdoliva S. et al. Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J Cardiovasc Med (Hagerstown ) 2006; 7: 608—13.[Web of Science]
  • Hirsch AT, Criqui MH, Treat-Jacobson D. et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317—24.[Abstract/Free Full Text]
  • Bhatt DL, Steg PG, Ohman EM et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180—89.[Abstract/Free Full Text]
  • Steg PG, Bhatt DL, Wilson PW et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197—206.[Abstract/Free Full Text]
  • Libby P., Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135—43.[Abstract/Free Full Text]
  • Wilson AM, Ryan MC, Boyle AJ The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006; 106: 291—97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brevetti G., Schiano V., Chiariello M. Cellular adhesion molecules and peripheral arterial disease. Vasc Med 2006; 11: 39—47.[Abstract/Free Full Text]
  • Silvestro A., Brevetti G., Schiano V., Scopacasa F., Chiariello M. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost 2005; 93: 559—63.[Web of Science][Medline] [Order article via Infotrieve]
  • Violi F., Criqui M., Longoni A., Castiglioni C. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. Atherosclerosis 1996; 120: 25—35.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Torzewski M., Rist C., Mortensen RF et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 2094—99.[Abstract/Free Full Text]
  • Vainas T., Stassen FR, de Graff R. et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 2005; 42: 243—51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rossi E., Biasucci LM, Citterio F. et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002; 105: 800—803.[Abstract/Free Full Text]
  • Tsimikas S., Willerson JT, Ridker PM C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006; 47(8 suppl): C19—C31.[Abstract/Free Full Text]
  • Folsom AR, Chambless LE, Ballantyne CM et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006; 166: 1368—73.[Abstract/Free Full Text]
  • Haverkate F., Thompson SG, Pyke SD, Gallimore JR, Pepys MB Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462—66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Retterstol L., Eikvar L., Bohn M., Bakken A., Erikssen J., Berg K. C-reactive protein predicts death in patients with previous premature myocardial infarction — a 10 year follow-up study. Atherosclerosis 2002; 160: 433—40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wang TJ, Gona P., Larson MG et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631—39.[Abstract/Free Full Text]
  • Danesh J., Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387—97.[Abstract/Free Full Text]
  • Cushman M., Arnold AM, Psaty BM et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study. Circulation 2005; 112: 25—31.[Abstract/Free Full Text]
  • Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499—511.[Free Full Text]
  • Owens CD, Ridker PM, Belkin M. et al. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg 2007; 45: 2—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pasceri V., Willerson JT, Yeh ET Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165—68.[Abstract/Free Full Text]
  • Verma S., Li SH, Badiwala MV et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105: 1890—96.[Abstract/Free Full Text]
  • Li L., Roumeliotis N., Sawamura T., Renier G. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res 2004; 95: 877—83.[Abstract/Free Full Text]
  • Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med 1999; 340: 115—26.[Free Full Text]
  • Gokce N., Keaney JF Jr, Hunter LM et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41: 1769—75.[Abstract/Free Full Text]
  • Brevetti G., Silvestro A., Schiano V., Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle—brachial pressure index. Circulation 2003; 108: 2093—98.[Abstract/Free Full Text]
  • Pellegrino T., Storto G., Filardi PP et al. Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease. J Nucl Med 2005; 46: 1997—2002.[Abstract/Free Full Text]
  • Topol EJ, Smith J., Plow EF, Wang QK Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 2006;15 Spec No 2: R117—R123.[Abstract/Free Full Text]
  • Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CH Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425—28.[Abstract/Free Full Text]
  • McDermott MM, Greenland P., Green D. et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003; 107: 3191—98.[Abstract/Free Full Text]
  • McDermott MM, Liu K., Guralnik JM et al. Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci 2006; 61: 374—79.
  • Giri J., McDermott MM, Greenland P. et al. Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 2006; 47: 998—1004.[Abstract/Free Full Text]

Vascular Medicine, Vol. 12, No. 4, 343-350 (2007)
DOI: 10.1177/1358863X07083278
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
T. Mueller, B. Dieplinger, W. Poelz, G. Endler, O. F. Wagner, and M. Haltmayer
Amino-Terminal Pro-B-Type Natriuretic Peptide as Predictor of Mortality in Patients with Symptomatic Peripheral Arterial Disease: 5-Year Follow-Up Data from the Linz Peripheral Arterial Disease Study
Clin. Chem., January 1, 2009; 55(1): 68 - 77.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haugen, S.
Right arrow Articles by Hiatt, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugen, S.
Right arrow Articles by Hiatt, W. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?